Renagel /01459901/


Indications and Reactions:

Role Indications Reactions
Secondary
Hyperphosphataemia 45.5%
Product Used For Unknown Indication 45.5%
Drug Use For Unknown Indication 9.1%
Hypophosphataemia 50.0%
Osteonecrosis 50.0%
Concomitant
Product Used For Unknown Indication 31.2%
Nuclear Magnetic Resonance Imaging 12.3%
Hyperphosphataemia 9.3%
Hypertension 8.6%
Nuclear Magnetic Resonance Imaging Brain 5.7%
Hyperparathyroidism Secondary 4.4%
Angiogram 4.1%
Pain 4.1%
Dialysis 3.1%
Anticoagulant Therapy 2.1%
Gastrooesophageal Reflux Disease 2.0%
Anaemia 1.8%
Chemotherapy 1.8%
Haemodialysis 1.8%
Arthralgia 1.5%
Vitamin Supplementation 1.5%
Depression 1.3%
Blood Cholesterol Increased 1.1%
Dry Eye 1.1%
Mineral Supplementation 1.1%
Nephrogenic Systemic Fibrosis 21.1%
Vomiting 17.3%
Tremor 7.5%
Parathyroid Haemorrhage 5.3%
Wound Infection Staphylococcal 4.5%
Pneumonia 3.8%
Wound 3.8%
Hypotension 3.0%
Off Label Use 3.0%
Putamen Haemorrhage 3.0%
Reflux Oesophagitis 3.0%
Respiratory Failure 3.0%
Splenomegaly 3.0%
Therapeutic Response Decreased 3.0%
Toe Amputation 3.0%
Ventricular Tachycardia 3.0%
Wheelchair User 3.0%
Pseudomembranous Colitis 2.3%
Renal Failure Chronic 2.3%
Shunt Malfunction 2.3%

Drug Data